BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10383075)

  • 1. Biochemical studies on leukocyte and fibroblast human beta-galactosidase.
    Coelho JC; Sopelsa AM; Tobo PR; Severini MH; Silva CD; Giugliani R
    Clin Biochem; 1999 Apr; 32(3):167-70. PubMed ID: 10383075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of beta-galactosidase in leukocytes and fibroblasts of GM1 gangliosidosis heterozygotes compared to normal subjects.
    Sopelsa AM; Severini MH; Da Silva CM; Tobo PR; Giugliani R; Coelho JC
    Clin Biochem; 2000 Mar; 33(2):125-9. PubMed ID: 10751590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-D-galactosidase activities in juvenile GM1-gangliosidosis.
    Hultberg B; Sjöblad S
    Acta Neurol Scand; 1978 Oct; 58(4):221-9. PubMed ID: 31052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.
    Condori J; Acosta W; Ayala J; Katta V; Flory A; Martin R; Radin J; Cramer CL; Radin DN
    Mol Genet Metab; 2016 Feb; 117(2):199-209. PubMed ID: 26766614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte and plasma beta-D-fucosidase: identity with beta-D-galactosidase.
    Den Tandt WR
    Biochem Med Metab Biol; 1987 Dec; 38(3):331-7. PubMed ID: 3124873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turnover of beta-galactosidase in fibroblasts from patients with genetically different types of beta-galactosidase deficiency.
    Van Diggelen OP; Schram AW; Sinnott ML; Smith PJ; Robinson D; Galjaard H
    Biochem J; 1981 Oct; 200(1):143-51. PubMed ID: 6800355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the beta-galactosidase-carboxypeptidase complex in GM1-gangliosidosis and beta-galactosialidosis fibroblasts.
    D'Agrosa RM; Hubbes M; Zhang S; Shankaran R; Callahan JW
    Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):833-8. PubMed ID: 1497621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B.
    Front S; Biela-Banaś A; Burda P; Ballhausen D; Higaki K; Caciotti A; Morrone A; Charollais-Thoenig J; Gallienne E; Demotz S; Martin OR
    Eur J Med Chem; 2017 Jan; 126():160-170. PubMed ID: 27750150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient high-level expression of beta-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA.
    Balestrin RC; Baldo G; Vieira MB; Sano R; Coelho JC; Giugliani R; Matte U
    Braz J Med Biol Res; 2008 Apr; 41(4):283-8. PubMed ID: 18392450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential action of galactose as a "chemical chaperone": increase of beta galactosidase activity in fibroblasts from an adult GM1-gangliosidosis patient.
    Caciotti A; Donati MA; d'Azzo A; Salvioli R; Guerrini R; Zammarchi E; Morrone A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):160-4. PubMed ID: 18571950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular form and subcellular distribution of acid beta-galactosidase in fibroblasts from patients with GM1 gangliosidosis, Morquio B disease and galactosialidosis.
    Takiyama N; Itoh K; Shimmoto M; Nishimoto J; Inui K; Sakuraba H; Suzuki Y
    Brain Dev; 1997 Mar; 19(2):126-30. PubMed ID: 9105659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mucopolysaccharidosis type I heterozygotes based on the biochemical characteristics of leukocyte alpha-L-iduronidase.
    Mandelli J; Wajner A; Pires RF; Giugliani R; Coelho JC
    Arch Med Res; 2002; 33(1):20-4. PubMed ID: 11825626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis.
    Zhang S; Bagshaw R; Hilson W; Oho Y; Hinek A; Clarke JT; Callahan JW
    Biochem J; 2000 Jun; 348 Pt 3(Pt 3):621-32. PubMed ID: 10839995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of acid beta-galactosidase deficiency in GM1 gangliosidosis human fibroblasts by retrovirus vector-mediated gene transfer: higher efficiency of release and cross-correction by the murine enzyme.
    Sena-Esteves M; Camp SM; Alroy J; Breakefield XO; Kaye EM
    Hum Gene Ther; 2000 Mar; 11(5):715-27. PubMed ID: 10757351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fluorescent probe for GM1 gangliosidosis related β-galactosidase: N-(dansylamino)hexylaminocarbonylpentyl-1,5-dideoxy-1,5-imino-D-galactitol.
    Fröhlich RF; Fantur K; Furneaux RH; Paschke E; Stütz AE; Wicki J; Withers SG; Wrodnigg TM
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6872-5. PubMed ID: 21974950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early proteolytic cleavage with loss of a C-terminal fragment underlies altered processing of the beta-galactosidase precursor in galactosialidosis.
    Okamura-Oho Y; Zhang S; Hilson W; Hinek A; Callahan JW
    Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):787-94. PubMed ID: 8611156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neutral beta-galactosidase from the hepatopancreas of the shrimp Penaeus monodon (Crustacea: Decapoda): dimeric and sialyated.
    Chuang NN
    Comp Biochem Physiol B; 1990; 96(4):747-51. PubMed ID: 20506608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the properties and bile salt specificities of galactosylceramide and lactosyl ceramide beta-galactosidase activities in human leucocytes and fibroblasts.
    Poulos A; Beckman K
    Clin Chim Acta; 1980 Feb; 101(2-3):277-85. PubMed ID: 6766828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microassay for acid beta-galactosidase activity toward asialofetuin.
    Mutoh T; Naoi M; Sobue I; Kiuchi K; Nagatsu T
    Clin Chim Acta; 1985 Nov; 152(3):307-14. PubMed ID: 2415273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in β-galactosidase deficiency.
    Higaki K; Li L; Bahrudin U; Okuzawa S; Takamuram A; Yamamoto K; Adachi K; Paraguison RC; Takai T; Ikehata H; Tominaga L; Hisatome I; Iida M; Ogawa S; Matsuda J; Ninomiya H; Sakakibara Y; Ohno K; Suzuki Y; Nanba E
    Hum Mutat; 2011 Jul; 32(7):843-52. PubMed ID: 21520340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.